Fusobacterium nucleatum Enhances the Efficacy of PD-L1 Blockade in Colorectal Cancer

By
Justin.choi
-
0
247
Fusobacterium nucleatum induces different immune responses in colorectal cancer (CRC) with different microsatellite-instability statuses. Scientists investigated the effect of F. nucleatum on anti-PD-L1 therapy in CRC.
[Signal Transduction and Targeted Therapy]

Sorry, but the selected Zotpress account can't be found.

Full Article